What Patients with Lupus Want You to Know
During a series of interviews with patients who have systemic lupus erythematosus, issues related to medication side effects, supplement use, depression and support groups, as well as concerns about race and activities of daily living arose. The interviews gave me a better understanding of what patients with lupus wish their physicians knew. I am grateful... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - August 11, 2023 Category: Rheumatology Authors: Jacqueline Jansz, MD, with Nadera Sweiss, MD Tags: Conditions Home Slider Patient Perspective SLE (Lupus) dietary supplement Mental Health side effect SLE Resource Center Source Type: research
Pegloticase Plus Methotrexate Effective for Uncontrolled Gout
The 12-month results of the MIRROR study show pegloticase co-administered with methotrexate is beneficial for patients with uncontrolled gout. (Source: The Rheumatologist)
Source: The Rheumatologist - August 8, 2023 Category: Rheumatology Authors: Glen Rodman Tags: Conditions Crystal Arthritis ACR Open Rheumatology Gout Gout Resource Center Methotrexate pegloticase serum urate levels Source Type: research
Implications of Florida ’s Electronic Health Records Data Storage Law
Healthcare is a high-priority target for cyber criminals. State-level measures, such as a new Florida law, fail to address the root problems of data security but may affect how providers manage patient data. (Source: The Rheumatologist)
Source: The Rheumatologist - August 7, 2023 Category: Rheumatology Authors: Joseph Cantrell, JD Tags: Legislation & Advocacy Practice Management cyber security electronic health record (EHR) patient data state legislation Source Type: research
Guideline for Integrative RA Interventions Released
Discussions between clinicians and their patients about complementary aspects of their care just got easier with the release of the 2022 ACR Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. (Source: The Rheumatologist)
Source: The Rheumatologist - August 3, 2023 Category: Rheumatology Authors: Ruth Jessen Hickman, MD Tags: American College of Rheumatology Conditions Guidelines Rheumatoid Arthritis RA Resource Center Source Type: research
Treat to Target Lowers the Risk of Fracture in Patients with Gout
Using data from the U.K.’s Health Improvement Network, a primary care database, Wei et al. examined whether urate-lowering therapy (ULT) in a treat-to-target approach for patients with gout reduces the risk of fracture. (Source: The Rheumatologist)
Source: The Rheumatologist - July 26, 2023 Category: Rheumatology Authors: Arthritis & Rheumatology Tags: Conditions Crystal Arthritis fracture risk Fractures Gout Gout Resource Center serum urate levels Source Type: research
The Rheumatologist Honored with 2 Awards of Excellence
We are honored to announce that The Rheumatologist has received two Awards of Excellence from APEX 2023 for content published in calendar year 2022: an Award of Excellence in the category of Public Health Concerns—Health & Medical for the editorial supplement to the April issue, COVID-19: What We Know, and an Award of Excellence for... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - July 26, 2023 Category: Rheumatology Authors: Keri Losavio Tags: Awards Professional Topics APEX 2023 COVID-19 Source Type: research
Trailblazers in Rheumatology
We were sad to learn that Rodanthi C. Kitridou, MD, MACR, passed away July 6, 2023, after a long illness. Dr. Kitridou was the longtime director of clinical rheumatology at at LAC/USC Medical Center in Los Angeles. (Source: The Rheumatologist)
Source: The Rheumatologist - July 26, 2023 Category: Rheumatology Authors: Staff Tags: Career Development Education & Training From the College Professional Topics Profiles AC&R American College of Rheumatology REF Research rheumatologist Rheumatology Research Foundation Source Type: research
CMS Proposes Reimbursement Cuts for CY24
On July 13, the Centers for Medicare and Medicaid Services released the CY 2024 Medicare Physician Fee Schedule Notice of Proposed Rulemaking. This annual rule outlines policies related to provider reimbursement, coverage of telehealth services, review of specific codes, refinement of evaluation and management codes and updates to the Quality Payment Program. (Source: The Rheumatologist)
Source: The Rheumatologist - July 25, 2023 Category: Rheumatology Authors: From the College Tags: Legislation & Advocacy ACR advocacy efforts Medicare Physician Fee Schedule (MPFS) Medicare reimbursement rate telehealth Source Type: research
Measuring Up: A Review of the ACR-Owned Quality Measures
Since 2006, the Centers for Medicaid & Medicare Services (CMS) has increasingly driven clinicians to focus on and improve quality. Quality measures help clinicians measure how well they treat their patients. By tracking their performance, clinicians can identify opportunities to improve patient care while meeting federal reporting requirements. Breaking Down Quality Measures The CMS has... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - July 25, 2023 Category: Rheumatology Authors: Allison Plitman, MPA Source Type: research
The Voice of Rheumatology: The Most Important Rheumatology Coalition You ’ ve Never Heard Of
The Voice of Rheumatology was established as an informal coalition to aid effective collaborations on issues important to the rheumatology community. The group has grown to become an integral mechanism for the exchange of information among groups including the ACR, Arthritis Foundation, Coalition of State Rheumatology Organizations (CSRO), Alliance for Women in Rheumatology and more to strengthen partnerships on a range of federal, state and regulatory issues. (Source: The Rheumatologist)
Source: The Rheumatologist - July 25, 2023 Category: Rheumatology Authors: Joseph Cantrell, JD Tags: Legislation & Advocacy partnership Voice of Rheumatology Source Type: research
The ACR Opposes New AI-Based Decision-Making Platform
On July 1, Blue Cross Blue Shield of North Carolina introduced a machine-learning technology platform to make decisions about patients’ care and treatment. The ACR opposes its use on grounds that it may harm patients’ access to treatment and undermine the doctor-patient relationship. (Source: The Rheumatologist)
Source: The Rheumatologist - July 25, 2023 Category: Rheumatology Authors: From the College Tags: Billing/Coding Legislation & Advocacy ACR Insurance Subcommittee (ISC) artificial intelligence Blue Cross Blue Shield Medical decision making Source Type: research
Mind the Gap: Working to Reduce Healthcare Disparities in Pediatric Rheumatology
Experts addressed how changes in research & clinical care can improve outcomes for children experiencing healthcare disparities during a session at the 2023 Pediatric Rheumatology Symposium. (Source: The Rheumatologist)
Source: The Rheumatologist - July 24, 2023 Category: Rheumatology Authors: Jason Liebowitz, MD Tags: Meeting Reports health disparities Pediatric Rheumatology PRSYM Source Type: research
Do NSAIDs Mask MRI Findings in Patients with Axial Spondyloarthritis?
Research suggests the use of non-steroidal anti-inflammatory drugs may mask the amount of sacroiliac joint inflammation found on MRI in patients with axial spondyloarthritis. (Source: The Rheumatologist)
Source: The Rheumatologist - July 17, 2023 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates Meeting Reports axSpA British Society for Rheumatology Annual Conference Magnetic resonance imaging (MRI) sacroiliac joints sacroiliitis Source Type: research
A Dual Inhibitor Treatment for RA?
TLL-018, a Janus kinase 1/tyrosine kinase 2 inhibitor, proved more effective for treating patients with RA than tofacitinib, according to a study by Zeng et al. (Source: The Rheumatologist)
Source: The Rheumatologist - July 17, 2023 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates Meeting Reports Source Type: research
Marching to the Biosimilar Beat: Questions on Rollout Remain
The availability of biosimilars for the treatment of patients with rheumatic diseases exploded in 2023. Here’s where we stand and what to expect going forward. (Source: The Rheumatologist)
Source: The Rheumatologist - July 12, 2023 Category: Rheumatology Authors: Ruth Jessen Hickman, MD Tags: Drug Updates adalimumab Biosimilars Source Type: research
